Quarterly ResultJul 28, 2026, 05:11 PM
Ashland Q3 Sales $497M, Adj. EBITDA $109M; Reaffirms FY26 Outlook
AI Summary
Ashland Inc. announced preliminary third-quarter fiscal year 2026 results, with sales increasing 7% to $497 million and net income of $16 million. Adjusted EBITDA decreased 4% to $109 million, primarily due to lower Specialty Additives and Intermediates earnings, despite growth in Life Sciences and Personal Care. The company reaffirmed its full-year sales and Adjusted EBITDA guidance but revised its adjusted EPS outlook to low-to-mid-single digit growth due to a higher tax rate.
Key Highlights
- Q3 2026 sales increased 7% year-over-year to $497 million.
- Q3 2026 net income was $16 million, or $0.35 per diluted share.
- Q3 2026 Adjusted EBITDA was $109 million, down 4% year-over-year.
- Life Sciences segment sales grew 11% to $180 million.
- Personal Care segment sales increased 5% to $155 million.
- Reaffirmed full-year 2026 sales guidance of $1,835-$1,870 million.
- Reaffirmed full-year 2026 Adjusted EBITDA guidance of $385-$400 million.
- Adjusted Diluted EPS outlook revised to low-to-mid-single digit growth.
Price Impact
More from ASH